A research done by doctors at Eastern Piedmont University in Novara, Italy, shows that diabetes is a negative prognostic factor in patients who have suffered a myocardial infarction. STEMI, that is ST-segment myocardial infarction elevation, has indication for primary angioplasty, a procedure that involves coronary artery revascularization, which is the treatment of choice for this medical condition.
The study evaluated 6298 patients who underwent primary angioplasty (post-STEMI) and, of these, about 15% had diabetes. After follow-up, it was found that in patients with diabetes mortality rates(19.1 versus 7.4 percent), reinfarction (10.4 versus 7.5 percent), stent thrombosis (7.6 versus 4.8 percent) were higher compared to those without diabetes. Also, it was found that patients with diabetes had other associated conditions such as hypercholesterolemia, hypertension and longer ischemia time.
The study points out the importance of the prevention and control of diabetes, which is an important cardiovascular risk factor. It is good to know that diabetes can not only contribute to a heart attack occurrence, but after infarction, it is a negative prognostic factor. In addition, it is known that patients with untreated diabetes have silent ischemia, which means that they cannot feel pain during heart attack. So, eat healthy and do sports, to lower the risk of cardiovascular disease and diabetes!